PUBLISHER: The Business Research Company | PRODUCT CODE: 1932730
PUBLISHER: The Business Research Company | PRODUCT CODE: 1932730
Liquid chromatography-mass spectrometry (LC-MS) is an analytical method used to separate, identify, and quantify components within mixtures. It merges the separation capabilities of liquid chromatography with the detection and identification abilities of mass spectrometry. LC-MS is widely employed for analyzing intricate samples due to its high sensitivity and specificity. Its primary objective is to offer comprehensive insights into sample composition, aiding researchers and analysts in comprehending its chemical characteristics and attributes.
LC-MS encompasses various types such as normal-phase liquid chromatography (NPLC), reversed-phase liquid chromatography (RPLC), ion exchange liquid chromatography (IELC), size exclusion liquid chromatography (SELC), high-performance liquid chromatography (HPLC), ultra-high pressure liquid chromatography (UHPLC), low-pressure liquid chromatography (LPLC), and others. NPLC involves a polar stationary phase typically made of silica or alumina, paired with a non-polar mobile phase such as hexane or chloroform. These methodologies encompass single mass spectrometry, hybrid mass spectrometry, and other platforms. They find application across diverse sectors including pharmaceuticals, biotechnology, petrochemicals, environmental testing, and food and beverage analysis, serving biotechnological and pharmaceutical industries, research and diagnostic laboratories, as well as governmental and public entities.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Tariffs are impacting the liquid chromatography mass spectrometry market by increasing the cost of imported mass analyzers, ion sources, vacuum systems, high-precision pumps, and electronic control modules. Pharmaceutical and biotechnology laboratories in North America and Europe are most affected due to reliance on imported high-end LC-MS instruments, while Asia-Pacific manufacturers face pricing pressure on exports. These tariffs are raising capital investment requirements and delaying laboratory equipment upgrades. However, they are also encouraging localized assembly, regional supplier partnerships, and innovation in modular and cost-optimized LC-MS platforms.
The liquid chromatography mass spectrometry market research report is one of a series of new reports from The Business Research Company that provides liquid chromatography mass spectrometry market statistics, including the liquid chromatography mass spectrometry industry global market size, regional shares, competitors with liquid chromatography mass spectrometry market share, detailed liquid chromatography mass spectrometry market segments, market trends, and opportunities, and any further data you may need to thrive in the liquid chromatography mass spectrometry industry. These liquid chromatography mass spectrometry market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The liquid chromatography mass spectrometry (lc-ms) market size has grown rapidly in recent years. It will grow from $7.73 billion in 2025 to $8.83 billion in 2026 at a compound annual growth rate (CAGR) of 14.2%. The growth in the historic period can be attributed to expansion of pharmaceutical r&d, growth in analytical laboratories, rising demand for complex sample analysis, advancements in chromatography systems, increased government research funding.
The liquid chromatography mass spectrometry (lc-ms) market size is expected to see rapid growth in the next few years. It will grow to $14.28 billion in 2030 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to precision medicine growth, increasing biologics development, automation of analytical workflows, demand for high-throughput analysis, integration of ai-driven data interpretation. Major trends in the forecast period include growing adoption in drug development, expansion of proteomics and metabolomics, demand for high-sensitivity analytical techniques, integration with advanced data analysis software, increasing use in regulatory testing.
The growing number of clinical trials is expected to drive the liquid chromatography-mass spectrometry (LC-MS) market going forward. Clinical trials involve evaluating new medical treatments, interventions, or therapies in humans to determine their safety and efficacy. The rise in clinical trials is driven by advancements in medical research, the increasing prevalence of chronic diseases, regulatory support and incentives, greater investment in R&D, and the growth of precision medicine. LC-MS supports clinical trials by providing precise and reliable analysis of biological samples, enabling identification and quantification of drugs, metabolites, and biomarkers, which aids in drug efficacy and safety evaluations, pharmacokinetic and pharmacodynamic studies, and personalized medicine approaches. For example, according to ClinicalTrials.gov, a US-based clinical trial registry, 477,234 clinical trials were registered globally in 2023, up from 437,512 trials in 2022. Therefore, the increasing number of clinical trials is propelling the LC-MS market.
Major companies in the LC-MS market are focusing on developing advanced instruments to enhance analytical sensitivity, accuracy, and speed, improving detection and quantification of complex biological and chemical compounds. High-performance LC-MS instruments are designed to deliver exceptional sensitivity, accuracy, and throughput for complex sample analysis. For instance, in June 2024, Thermo Fisher Scientific, a US-based medical device manufacturer, launched Stellar, a high-performance LC-MS instrument. Stellar is designed for highly multiplexed targeted quantitation, combining fast throughput, high sensitivity, and ease of use to advance translational omics research and facilitate more efficient breakthrough discoveries.
In April 2025, Bruker Corporation, a US-based provider of scientific instruments and analytical mass spectrometry systems, acquired a majority stake in RECIPE Chemicals + Instruments GmbH for an undisclosed amount. Through this acquisition, Bruker aims to expand its clinical mass spectrometry capabilities by integrating RECIPE's diagnostic assay kits and workflows with its LC MS/MS and high-throughput mass spectrometry platforms, providing a comprehensive end-to-end solution for therapeutic drug monitoring and small-molecule diagnostics. RECIPE Chemicals + Instruments GmbH is a Germany-based provider of in vitro diagnostic assay kits for LC MS/MS, HPLC, and ICP MS, including therapeutic drug-monitoring products under its ClinMASS and ClinDART lines.
Major companies operating in the liquid chromatography mass spectrometry (lc-ms) market are Agilent Technologies Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Waters Corporation, Shimadzu Corporation, Bruker Corporation, JEOL Ltd., Hitachi Ltd., PerkinElmer Inc., JASCO Corporation, Phenomenex Inc., GL Sciences Inc., Hamilton Company, Advion Inc., KNAUER Wissenschaftliche Gerate GmbH, VWR International LLC, Sartorius AG, Metrohm AG, Analytik Jena GmbH, CEM Corporation
North America was the largest region in the liquid chromatography mass spectrometry (LC-MS) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liquid chromatography mass spectrometry (lc-ms) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the liquid chromatography mass spectrometry (lc-ms) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The liquid chromatography mass spectrometry (LC-MS) market consists revenues earned by entities by providing services such as sample preparation, method development and validation, quantitative and qualitative analysis, and biopharmaceutical analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The liquid chromatography mass spectrometry market also includes sales of LC-MS systems, liquid chromatographs, mass spectrometers, solvents, buffers, columns, and sample prep kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Liquid Chromatography Mass Spectrometry (LC-MS) Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses liquid chromatography mass spectrometry (lc-ms) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for liquid chromatography mass spectrometry (lc-ms) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The liquid chromatography mass spectrometry (lc-ms) market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.